ACSL1-induced ferroptosis and platinum resistance in ovarian cancer by increasing FSP1 N-myristylation and stability
Open Access
- 8 March 2023
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-12
Abstract
Reprogramming of lipid metabolism, which modulates energy utilization and cell signaling, maintains cell survival and promotes cancer metastasis in cancer cells. Ferroptosis is a type of cell necrosis caused by an overload of lipid oxidation, which has been demonstrated to be involved in cancer cell metastasis. However, the mechanism by which fatty acid metabolism regulates the anti-ferroptosis signaling pathways is not fully understood. The formation of ovarian cancer spheroids helps to counteract the hostile microenvironment of the peritoneal cavity with low oxygen, shortage of nutrients, and subjected to platinum therapy. Previously, we demonstrated that Acyl-CoA synthetase long-chain family member 1 (ACSL1) promotes cell survival and peritoneal metastases in ovarian cancer, but the mechanism is still not well elucidated. In this study, we demonstrate that the formation of spheroids and under exposure to platinum chemotherapy increased the levels of anti-ferroptosis proteins as well as ACSL1. Inhibition of ferroptosis can enhance spheroid formation and vice versa. Genetic manipulation of ACSL1 expression showed that ACSL1 reduced the level of lipid oxidation and increased the resistance to cell ferroptosis. Mechanistically, ACSL1 increased the N-myristoylation of ferroptosis suppressor 1 (FSP1), resulting in the inhibition of its degradation and translocation to the cell membrane. The increase in myristoylated FSP1 functionally counteracted oxidative stress-induced cell ferroptosis. Clinical data also suggested that ACSL1 protein was positively correlated with FSP1 and negatively correlated with the ferroptosis markers 4-HNE and PTGS2. In conclusion, this study demonstrated that ACSL1 enhances antioxidant capacity and increases ferroptosis resistance by modulating the myristoylation of FSP1.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2022A1515012240, 2021A1515011621)
- Macau University of Science and Technology Foundation (0016/2020/A1)
- Universidade de Macau (MYRG2022-00240-FHS)
This publication has 32 references indexed in Scilit:
- Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancerCell Death & Disease, 2018
- Iron addiction: a novel therapeutic target in ovarian cancerOncogene, 2017
- Autophagy promotes ferroptosis by degradation of ferritinAutophagy, 2016
- Anoikis resistance is a critical feature of highly aggressive ovarian cancer cellsOncogene, 2014
- “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?Gynecologic Oncology, 2014
- Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant MetabolismPLOS ONE, 2014
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic FunctionsPLOS ONE, 2013
- CAMERA: An Integrated Strategy for Compound Spectra Extraction and Annotation of Liquid Chromatography/Mass Spectrometry Data SetsAnalytical Chemistry, 2011
- Adipose Acyl-CoA Synthetase-1 Directs Fatty Acids toward β-Oxidation and Is Required for Cold ThermogenesisCell Metabolism, 2010
- The roles of intracellular protein-degradation pathways in neurodegenerationNature, 2006